Comparison Between Two Volumes Of 70% Alcohol In Single Injection Ultrasound Guided Celiac Plexus Neurolysis

suez canal university hospital0 个研究点目标入组 32 人开始时间: 2018年3月18日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•1.Adult patients of either sex 18 years or older.
•2.Patients with the diagnosis of histologically proven or radiologically consistent, surgically unresectable upper abdominal malignancies (including gastric, pancreatic, biliary system).
•3.Patients with visual analogue scale (VAS) scores of equal to or more than 4/10 due to cancer related visceral pain in spite of adequate medical management (defined as the highest analgesia possible without intolerable side effects using opioid and non-opioid drugs according to the world health organization analgesic step ladder).

•1.Refusal of participation in the study.
•2.Patients received celiac or splanchnic blocks previously as a neurolytic management for cancer pain or those who did not respond to the diagnostic anesthetic block.
•3.Patients received intrathecal or epidural interventional implantable devices for cancer pain.
•4.Patients allergic to local anesthetics used in the diagnostic block.
•5.Patients with coagulopathies not correctable with active medical management.
•6.Patients with uncontrolled hypotension.
•7.Patients suffering from pain not related to the abdominal malignancy such as neuropathic pain or central pain conditions.
•8.Patients with documented metastatic lesions in other sites of the body contributing to pain severity.
•9.Patients with psychiatric disorders preventing adequate assessment and data collection.

发起方

suez canal university hospital